☰

Brian T. Kalet, Ph.D. - Publications

Affiliations: 
2007 Chemistry University of Colorado, Boulder, Boulder, CO, United States 
Area:
Biochemistry, Pharmaceutical Chemistry
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Pfaff LE, Kalet BT, Dailey DD, Duval DL. Abstract A23: Insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) drives growth, metastasis and chemoresistance in human and canine osteosarcoma Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-A23  0.372
2013 Kalet BT, Anglin SR, Handschy A, O'Donoghue LE, Halsey C, Chubb L, Korch C, Duval DL. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors. Plos One. 8: e68815. PMID 23874775 DOI: 10.1371/Journal.Pone.0068815  0.421
2013 Kalet BT, O'Donoghue LE, Duval DL. Abstract 3008: IGF2 mRNA binding protein 1 drives growth, metastasis and chemoresistance in osteosarcoma. Cancer Research. 73: 3008-3008. DOI: 10.1158/1538-7445.Am2013-3008  0.422
2008 Koch TH, Barthel BL, Kalet BT, Rudnicki DL, Post GC, Burkhart DJ. Anthracycline-formaldehyde conjugates and their targeted prodrugs. Topics in Current Chemistry. 283: 141-70. PMID 23605631 DOI: 10.1007/128_2007_4  0.481
2007 Kalet BT, McBryde MB, Espinosa JM, Koch TH. Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism. Journal of Medicinal Chemistry. 50: 4493-500. PMID 17696516 DOI: 10.1021/Jm070569B  0.673
2006 Burkhart DJ, Barthel BL, Post GC, Kalet BT, Nafie JW, Shoemaker RK, Koch TH. Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases. Journal of Medicinal Chemistry. 49: 7002-12. PMID 17125253 DOI: 10.1021/Jm060597E  0.658
2004 Burkhart DJ, Kalet BT, Coleman MP, Post GC, Koch TH. Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin. Molecular Cancer Therapeutics. 3: 1593-604. PMID 15634653  0.698
2004 Burke PJ, Kalet BT, Koch TH. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells. Journal of Medicinal Chemistry. 47: 6509-18. PMID 15588086 DOI: 10.1021/Jm049496B  0.712
Show low-probability matches.